TMCnet News
Bullinadvantage.com Presents The Daily Hot Stock Watchlist: (PINK SHEETS:KITD) (PINKSHEETS:BION) (PINKSHEETS:BORK) (OTCQB: SBFM)New York, Dec 26, 2012 (eTeligis.com via COMTEX) Bull in Advantage hereby designates the followingcompanies as part of our Hot Stock Watchlist today. For more top picks every day, be sure to subscribe to our daily reports.Copies of these reports may be found on our blog at:http://bluehorseshoestocks.com. KIT Digital, Inc. (PINK SHEETS:KITD) KIT Digital is a leading video management software and services company. Cosmos and Cloud, the company's video asset management systems, enable leading broadband media companies to produce, manage and deliver multiscreen socially-enabled video experiences to audiences wherever they are. KIT digital services nearly 2,500 clients in 50+ countries including some of the world's biggest brands, such as Airbus, The Associated Press, AT&T, BBC, BSkyB, Disney-ABC, Google, HP, Mediaset, MTV, News Corp, RCS Media Group, Sky Deutschland, Sky Italia, Telecom Argentina, Telecom Italia, Telefonica O2, Universal Studios, Verizon, Vodafone, VRT and Volkswagen. For updates and coverage, subscribe at http://bullinadvantage.com BioNitrogen Corp. (PINKSHEETS:BION) BioNitrogen is an American company focused on building fully operational, turnkey manufacturing facilities in the global marketplace to produce urea. Urea is a white, crystalline solid containing 46% nitrogen and is principally used in the agricultural industry as a crop fertilizer. For updates and coverage, subscribe at http://bullinadvantage.com Bourque Industries, Inc. (PINKSHEETS:BORK) Bourque Industries is a publicly-traded advanced materials science company based in Tucson, Arizona, that develops and produces metal alloys and related product applications using our revolutionary metal-alloying process, Kryron. For updates and coverage, subscribe at http://bullinadvantage.com Sunshine Biopharma, Inc. (OTCQB: SBFM) Sunshine Biopharma is a development stage pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer. The Company's lead anti-cancer compound, Adva-27a, is currently in late stage preclinical studies.. For updates and coverage, subscribe at http://bullinadvantage.com About Bull in Advantage: For over 10 years, the Bull in Advantage Network has been working tirelessly to provide the public with the #1 stock newsletter available. We scan thousands of stocks daily to find the very best 52-week low bounce-plays, high-volume momentum movers, and promising start-ups with unique business models. We also cover big board and blue-chip stocks along with related options trading ideas. We gather information on all of the best opportunities, and pass it along to you. What sets us apart from so many competitors is our coverage of multiple symbols each day. We strive to provide a diverse array of stocks with real potential, and present them in a very straightforward manner. Sign up for our free newsletter today, and welcome to the Bull in Advantage family! Sign up is always free at: http://bullinadvantage.com Disclaimer: The assembled information disseminated by Bull in Advantage is for informative purposes only, and is neither a solicitation to buy nor an offer to sell securities. Bull in Advantage LLC owners/operators are not licensed financial advisors or analysts in any jurisdiction whatsoever. Always do your own due diligence, and consult a financial advisor before making any investment. Full compensatory disclosure is available at http://bullinadvantage.com/disclaimer Contact: Bull in Advantage LLC Email: [email protected] Phone: (561) 228-1692 Source: Bull in Advantage LLC Associated Documentation:Link to submission on http://www.eteligis.comBull_in_Advantage,_LLC_12-26-2012_MEL_2.docx |